1. 61OSafety, anti-tumour activity, and biomarker results of the HER2-targeted bispecific antibody ZW25 in HER2-expressing solid tumours. (24th November 2019) Authors: Oh, D-Y; Hamilton, E; Hanna, D; Beeram, M; Lee, K-W; Kang, Y-K; Chaves, J; Lee, J-Y; Goodwin, R; Vaklavas, C; Rha, S-Y; Elimova, E; Mayordomo, J; Ferrario, C; Cobleigh, M; Fortenberry, A; Rowse, G; Gray, T; Lai, R; Bernstam, F Meric Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-005Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy in the phase 2 SUMMIT 'basket' trial. (2nd July 2019) Authors: Harding, J; Cleary, J; Shapiro, G; Braña, I; Moreno, V; Quinn, D; Borad, M; Loi, S; Spanggaard, I; Stemmer, S; Dujka, M; Cutler, R; Xu, F; Eli, L; Macia, S; Lalani, A; Bryce, R; Bernstam, F Meric; Solit, D; Hyman, D Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SO-003Debio 1347 in patients with gastrointestinal cancers harboring an FGFR gene fusion: preliminary results. (2nd July 2019) Authors: Matos, I; Goyal, L; Cleary, J; Voss, M; Oh, D; Bernstam, F Meric; Ng, C; Iyer, G; Ishii, N; Hu, Y; Chessex, A Vaslin; Pokorska-Bocci, A; Nicolas, V; Kirpicheva, Y; Zanna, C; Flaherty, K; Tabernero, J; Hyman, D Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗